Biotech Values

[DewDiligence]

Re: OGX-011

Agree with your post on all counts except your contention that the ISIS PR does not specify the hazard ratio. From the PR (#msg-33921631):

>>
Results currently indicate that patients in the OGX-011 arm have a death rate approximately 40% lower than patients in the control arm.
<<

An approximately 40% lower death rate means the HR is ~0.60 based on the events observed to date.